254 related articles for article (PubMed ID: 28552625)
81. Clinical Specialty Setting as Determinant of Management of Psoriatic Arthritis: A Cross-Sectional Brazilian Study.
da Silva Souza C; Goldenstein-Schainberg C; Alvarenga Anti Loduca Lima SM; Spelling Gormezano N; Ferreira Magalhães R; Ranza R
J Clin Rheumatol; 2022 Apr; 28(3):120-125. PubMed ID: 35325900
[TBL] [Abstract][Full Text] [Related]
82. Treatment practices and costs among patients with psoriatic arthritis: A Japanese hospital claims database analysis.
Inui K; Sato M; Esterberg E; Parikh RC; Kimura S; Torisu-Itakura H
Mod Rheumatol; 2021 Nov; 31(6):1179-1191. PubMed ID: 33559509
[TBL] [Abstract][Full Text] [Related]
83. Current and investigational treatment of psoriatic arthritis.
Prasad R; Gladman D
Expert Opin Investig Drugs; 2004 Feb; 13(2):139-50. PubMed ID: 14996648
[TBL] [Abstract][Full Text] [Related]
84. Association of physician specialty with psoriatic arthritis treatment and costs.
Maksabedian Hernandez EJ; Tkacz J; Zimmerman NM; Chan P; Limone B; Ogdie A; Karis E; Stolshek B
Am J Manag Care; 2021 Jul; 27(7):e226-e233. PubMed ID: 34314123
[TBL] [Abstract][Full Text] [Related]
85. The Psoriatic Arthritis Experience in Saudi Arabia from the Rheumatologist and Patient Perspectives.
Alhomood I; Fatani M; Bedaiwi M; Al Natour S; Erdogan A; Alsharafi A; Attar S
Curr Rheumatol Rev; 2023; 19(4):470-478. PubMed ID: 37194936
[TBL] [Abstract][Full Text] [Related]
86. Biologics and small molecules in the management of psoriatic arthritis: Reproduction related issues in female and male patients.
Fischer-Betz R; Østensen M
Expert Rev Clin Pharmacol; 2021 Aug; 14(8):979-989. PubMed ID: 33982647
[TBL] [Abstract][Full Text] [Related]
87. Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis.
Dures E; Taylor J; Shepperd S; Mukherjee S; Robson J; Vlaev I; Walsh N; Coates LC
Ann Rheum Dis; 2020 Aug; 79(8):1031-1036. PubMed ID: 32424031
[TBL] [Abstract][Full Text] [Related]
88. A Joint Consensus of Rheumatologists and Dermatologists on Early Detection and Effective Management of Psoriatic Arthritis: India's Perspective.
Chatterjee M; Nayak C; De A; Rajadhyaksha S; Singh GK; Kumar P; Balameena S; Kumar MH; Hema M; Choudhury GD; Pangtey GS; Singh J; Jain N
Indian J Dermatol; 2022; 67(4):479. PubMed ID: 36578740
[TBL] [Abstract][Full Text] [Related]
89. Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America.
Soriano ER; Zazzetti F; Alves Pereira I; Maldonado Cocco J; Feijó Azevedo V; Guerra G; Bautista-Molano W; Casasola JC; Vega Morales D; Gil DR; Lobosco S; Lawson F
Clin Rheumatol; 2020 Jun; 39(6):1859-1869. PubMed ID: 31993888
[TBL] [Abstract][Full Text] [Related]
90. Optimal Biologic Selection for Treatment of Psoriatic Arthritis: the Approach to Precision Medicine.
Miyagawa I; Nakayamada S; Tanaka Y
Curr Rheumatol Rep; 2019 Mar; 21(5):21. PubMed ID: 30891646
[TBL] [Abstract][Full Text] [Related]
91. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020.
Lortholary O; Fernandez-Ruiz M; Baddley JW; Manuel O; Mariette X; Winthrop KL
Ann Rheum Dis; 2020 Dec; 79(12):1532-1543. PubMed ID: 32963049
[TBL] [Abstract][Full Text] [Related]
92. Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.
Ogdie A; Alehashemi S; Love TJ; Jiang Y; Haynes K; Hennessy S; Choi H; Gelfand JM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):918-22. PubMed ID: 25044030
[TBL] [Abstract][Full Text] [Related]
93. The diagnosis and treatment of early psoriatic arthritis.
Anandarajah AP; Ritchlin CT
Nat Rev Rheumatol; 2009 Nov; 5(11):634-41. PubMed ID: 19806150
[TBL] [Abstract][Full Text] [Related]
94. Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.
Bedaiwi M; Al-Homood IA; El-Garf A; Uthman I; Sunna N; Nassier R; Mohamed H; Al Saleh J
Rheumatol Int; 2019 Aug; 39(8):1321-1329. PubMed ID: 31134289
[TBL] [Abstract][Full Text] [Related]
95. Psoriatic arthritis: performance of rheumatologists in daily practice.
Gorter S; van der Heijde DM; van der Linden S; Houben H; Rethans JJ; Scherpbier AJ; van der Vleuten CP
Ann Rheum Dis; 2002 Mar; 61(3):219-24. PubMed ID: 11830426
[TBL] [Abstract][Full Text] [Related]
96. Difficult to treat psoriatic arthritis - how should we manage?
Kumthekar A; Ashrafi M; Deodhar A
Clin Rheumatol; 2023 Sep; 42(9):2251-2265. PubMed ID: 37097525
[TBL] [Abstract][Full Text] [Related]
97. Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study.
Boehncke WH; Horváth R; Dalkiliç E; Lima SAL; Okada M; Hojnik M; Ganz F; Lubrano E
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2035-2043. PubMed ID: 32003056
[TBL] [Abstract][Full Text] [Related]
98. Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China.
Chen M; Zhang H; Chen Z; Dai SM
Front Immunol; 2021; 12():733708. PubMed ID: 34925316
[TBL] [Abstract][Full Text] [Related]
99. Current treatment of psoriatic arthritis.
Mease PJ
Rheum Dis Clin North Am; 2003 Aug; 29(3):495-511. PubMed ID: 12951864
[TBL] [Abstract][Full Text] [Related]
100. Current Medication Practices and Preferences Among Patients With Psoriatic Arthritis.
Schwartzman M; Abutalib Z; Mandl LA
J Clin Rheumatol; 2022 Mar; 28(2):55-61. PubMed ID: 35192589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
